Información del producto
Nombre:Imazamethabenz-methyl
Marca:Biosynth
Descripción:Imazamethabenz-methyl is a chemotherapeutic agent that has been shown to reduce the production of acid in the urine by inhibiting the enzyme fatty acid amide hydrolase. It has been shown to be clinically relevant for patients with atrial fibrillation, and is used as an adjuvant in cancer therapy. Imazamethabenz-methyl has also been found to inhibit de novo fatty acid synthesis and increase the glomerular filtration rate in rats. This drug is thought to have an effect on stem cells, cell factor, and dehydroascorbate reductase. Imazamethabenz-methyl blocks the activity of monoclonal antibodies responsible for myocardial infarction in mice.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:288.34 g/mol
Fórmula:C16H20N2O3
Pureza:Min. 95%